CLMT vs EFX · rev $4.19B vs P/E 54, rev $5.68B
Calumet Specialty Products Partners (CLMT) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CLMT currently screens at market cap $2.89B. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CLMT and EFX stock pages for the full models.
Not investment advice.